These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

431 related articles for article (PubMed ID: 36109713)

  • 61. Anti-SARS-CoV-2 antibodies in breast milk during lactation after infection or vaccination: A cohort study.
    Olearo F; Radmanesh LS; Felber N; von Possel R; Emmerich P; Pekarek N; Pfefferle S; Nörz D; Hansen G; Diemert A; Aepfelbacher M; Hecher K; Lütgehetmann M; Arck PC; Tallarek AC
    J Reprod Immunol; 2022 Sep; 153():103685. PubMed ID: 36029724
    [TBL] [Abstract][Full Text] [Related]  

  • 62. Association of Gestational Age at Coronavirus Disease 2019 (COVID-19) Vaccination, History of Severe Acute Respiratory Syndrome Coronavirus 2 (SARS-CoV-2) Infection, and a Vaccine Booster Dose With Maternal and Umbilical Cord Antibody Levels at Delivery.
    Yang YJ; Murphy EA; Singh S; Sukhu AC; Wolfe I; Adurty S; Eng D; Yee J; Mohammed I; Zhao Z; Riley LE; Prabhu M
    Obstet Gynecol; 2022 Mar; 139(3):373-380. PubMed ID: 34963127
    [TBL] [Abstract][Full Text] [Related]  

  • 63. Effect of COVID-19 Vaccination on the Levels of SARS-CoV-2 Neutralizing Antibodies in COVID-19 Naive, Hybrid, and Breakthrough SARS-CoV-2 Recovered Indian Individuals.
    Deepika G; Adarsh S; Sadhana Y; Srihitha M; Veeraiah N; Reddy DN
    J Lab Physicians; 2023 Sep; 15(3):377-382. PubMed ID: 37564232
    [No Abstract]   [Full Text] [Related]  

  • 64. Response and Duration of Serum Anti-SARS-CoV-2 Antibodies After Inactivated Vaccination Within 160 Days.
    Xu QY; Xue JH; Xiao Y; Jia ZJ; Wu MJ; Liu YY; Li WL; Liang XM; Yang TC
    Front Immunol; 2021; 12():786554. PubMed ID: 35003104
    [TBL] [Abstract][Full Text] [Related]  

  • 65. Analysis of IgG, IgA and IgM antibodies against SARS-CoV-2 spike protein S1 in convalescent and vaccinated patients with the Pfizer-BioNTech and CanSinoBio vaccines.
    Melgoza-González EA; Hinojosa-Trujillo D; Reséndiz-Sandoval M; Mata-Haro V; Hernández-Valenzuela S; García-Vega M; Bravo-Parra M; Arvizu-Flores AA; Valenzuela O; Velázquez E; Soto-Gaxiola A; Gómez-Meza MB; Pérez-Jacobo F; Villela L; Hernández J
    Transbound Emerg Dis; 2022 Jul; 69(4):e734-e745. PubMed ID: 34655457
    [TBL] [Abstract][Full Text] [Related]  

  • 66. [COVID-19 vaccination at the University of Alicante (Spain): detection of neutralizing antibodies against SARS-CoV-2 by rapid serological test, a cross-sectional study].
    Montagud AC; Vicente-Alcalde N; Gabaldón-Bravo EM; Hurtado-Sánchez JA; Montagud E; Egoavil CM; Chavarría-Alarcón E; Caballero P; Tuells J
    Rev Esp Salud Publica; 2023 Dec; 97():. PubMed ID: 38126466
    [TBL] [Abstract][Full Text] [Related]  

  • 67. Antibody responses to the BBV152 vaccine in individuals previously infected with SARS-CoV-2: A pilot study.
    Kumar NP; Padmapriyadarsini C; Uma Devi KR; Banurekha VV; Nancy A; Girish Kumar CP; Murhekar MV; Gupta N; Panda S; Babu S; Bhargava B
    Indian J Med Res; 2021 May; 153(5&6):671-676. PubMed ID: 34528524
    [TBL] [Abstract][Full Text] [Related]  

  • 68. Rapid, early, and potent Spike-directed IgG, IgM, and IgA distinguish asymptomatic from mildly symptomatic COVID-19 in Uganda, with IgG persisting for 28 months.
    Serwanga J; Ankunda V; Sembera J; Kato L; Oluka GK; Baine C; Odoch G; Kayiwa J; Auma BO; Jjuuko M; Nsereko C; Cotten M; Onyachi N; Muwanga M; Lutalo T; Fox J; Musenero M; Kaleebu P;
    Front Immunol; 2023; 14():1152522. PubMed ID: 37006272
    [TBL] [Abstract][Full Text] [Related]  

  • 69. Reduced humoral response 3 months following BNT162b2 vaccination in SARS-CoV-2 uninfected residents of long-term care facilities.
    Trigueros M; Pradenas E; Palacín D; Muñoz-López F; Ávila-Nieto C; Trinité B; Bonet-Simó JM; Isnard M; Moreno N; Marfil S; Rovirosa C; Puig T; Grau E; Chamorro A; Martinez A; Toledo R; Font M; Ara J; Carrillo J; Mateu L; Blanco J; Clotet B; Prat N; Massanella M;
    Age Ageing; 2022 May; 51(5):. PubMed ID: 35595256
    [TBL] [Abstract][Full Text] [Related]  

  • 70. Immunogenicity of COVID-19 Tozinameran Vaccination in Patients on Chronic Dialysis.
    Schrezenmeier E; Bergfeld L; Hillus D; Lippert JD; Weber U; Tober-Lau P; Landgraf I; Schwarz T; Kappert K; Stefanski AL; Sattler A; Kotsch K; Dörner T; Sander LE; Budde K; Halleck F; Kurth F; Corman VM; Choi M
    Front Immunol; 2021; 12():690698. PubMed ID: 34276681
    [TBL] [Abstract][Full Text] [Related]  

  • 71. Longitudinal profile of neutralizing and binding antibodies in vaccinated and convalescent COVID-19 cohorts by chemiluminescent immunoassays.
    Dou X; Wang E; Jiang R; Li M; Xiong D; Sun B; Zhang X
    Immun Inflamm Dis; 2022 Jun; 10(6):e612. PubMed ID: 35634960
    [TBL] [Abstract][Full Text] [Related]  

  • 72. A cohort analysis of SARS-CoV-2 anti-spike protein receptor binding domain (RBD) IgG levels and neutralizing antibodies in fully vaccinated healthcare workers.
    Padoan A; Cosma C; Della Rocca F; Barbaro F; Santarossa C; Dall'Olmo L; Galla L; Cattelan A; Cianci V; Basso D; Plebani M
    Clin Chem Lab Med; 2022 Jun; 60(7):1110-1115. PubMed ID: 35473824
    [TBL] [Abstract][Full Text] [Related]  

  • 73. Boosting of cross-reactive antibodies to endemic coronaviruses by SARS-CoV-2 infection but not vaccination with stabilized spike.
    Crowley AR; Natarajan H; Hederman AP; Bobak CA; Weiner JA; Wieland-Alter W; Lee J; Bloch EM; Tobian AAR; Redd AD; Blankson JN; Wolf D; Goetghebuer T; Marchant A; Connor RI; Wright PF; Ackerman ME
    Elife; 2022 Mar; 11():. PubMed ID: 35289271
    [TBL] [Abstract][Full Text] [Related]  

  • 74. Measurement of SARS-CoV-2 Antibody Titers Improves the Prediction Accuracy of COVID-19 Maximum Severity by Machine Learning in Non-Vaccinated Patients.
    Kurano M; Ohmiya H; Kishi Y; Okada J; Nakano Y; Yokoyama R; Qian C; Xia F; He F; Zheng L; Yu Y; Jubishi D; Okamoto K; Moriya K; Kodama T; Yatomi Y
    Front Immunol; 2022; 13():811952. PubMed ID: 35126396
    [TBL] [Abstract][Full Text] [Related]  

  • 75. Comparisons of Pediatric and Adult SARS-CoV-2-Specific Antibodies up to 6 Months after Infection, Vaccination, or Hybrid Immunity.
    Kim M; Cheng WA; Congrave-Wilson Z; Marentes Ruiz CJ; Turner L; Mendieta S; Jumarang J; Del Valle J; Lee Y; Fabrizio T; Allen EK; Thomas PG; Webby R; Gordon A; Pannaraj PS
    J Pediatric Infect Dis Soc; 2024 Jan; 13(1):91-99. PubMed ID: 38016076
    [TBL] [Abstract][Full Text] [Related]  

  • 76. Efficacy of antibody response following the vaccination of SARS-CoV-2 infected and noninfected healthcare workers by two-dose inactive vaccine against COVID-19.
    Dundar B; Karahangil K; Elgormus CS; Topsakal HNH
    J Med Virol; 2022 Jun; 94(6):2431-2437. PubMed ID: 35128700
    [TBL] [Abstract][Full Text] [Related]  

  • 77. [Antibody Response After Two Doses of Inactivated SARS-CoV-2 Vaccine in Healthcare Workers with and without Previous COVID-19 Infection: A Prospective Observational Study].
    Özgür D; Tütüncü EE
    Mikrobiyol Bul; 2022 Jan; 56(1):36-48. PubMed ID: 35088958
    [TBL] [Abstract][Full Text] [Related]  

  • 78. BNT162b2, mRNA-1273, and Sputnik V Vaccines Induce Comparable Immune Responses on a Par With Severe Course of COVID-19.
    Kaznadzey A; Tutukina M; Bessonova T; Kireeva M; Mazo I
    Front Immunol; 2022; 13():797918. PubMed ID: 35493476
    [TBL] [Abstract][Full Text] [Related]  

  • 79. Antibody response against SARS-CoV-2 variants of concern in children infected with pre-Omicron variants: An observational cohort study.
    Seery V; Raiden S; Russo C; Borda M; Herrera L; Uranga M; Varese A; Marcó Del Pont M; Chirino C; Erramuspe C; Álvarez LS; Lenoir M; Morales LD; Davenport C; Alarcón Flores A; Huespe Auchter S; Ruiz Y; Monsalvo L; Sastoque L; Gavazzi M; Mazzitelli I; Di Diego F; Longueira Y; Mazzitelli B; Sananez I; De Carli N; Biglione MM; Gómez Penedo JM; Ceballos A; Laufer N; Ferrero F; Geffner J; Arruvito L
    EBioMedicine; 2022 Sep; 83():104230. PubMed ID: 35988465
    [TBL] [Abstract][Full Text] [Related]  

  • 80. Lasting SARS-CoV-2 specific IgG Antibody response in health care workers from Venezuela, 6 months after vaccination with Sputnik V.
    Claro F; Silva D; Pérez Bogado JA; Rangel HR; de Waard JH
    Int J Infect Dis; 2022 Sep; 122():850-854. PubMed ID: 35690364
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 22.